ArticleJournal of experimental & clinical cancer research : CR2024
LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.
Qianlan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it